Besides its beneficial effect on dyslipidemia, simvastatin has cholesterol-independent pleiotropic effects on the physiological function of endothelial cells (ECs) by increasing endothelial nitric oxide synthase (eNOS) activity and nitric oxide (NO) production5, 6, 7, 8. This evidence concerns the gene NOS3 and metabolic syndrome.